Depending on the tumor type/model and the blocking agents used to impede M-CSFR signaling (Figure 2) (variable) effects of M-CSFR blockade on different aspects of cancer progression have been reported (Figure 1B). This evidence concerns the gene CSF1R and neoplasm.